Accordingly, anti-TNF treatment in IBD patients results in mucosal healing, associated to the reduction of CD14hi macrophages and to an accumulation of their CD206+ counterpart, showing pro-resolving activity [67]. Here, MRC1 is linked to inflammatory bowel disease.